scispace - formally typeset
C

Chandran S Abhinand

Researcher at University of Kerala

Publications -  9
Citations -  312

Chandran S Abhinand is an academic researcher from University of Kerala. The author has contributed to research in topics: Angiogenesis & Medicine. The author has an hindex of 4, co-authored 5 publications receiving 195 citations.

Papers
More filters
Journal ArticleDOI

VEGF-A/VEGFR2 signaling network in endothelial cells relevant to angiogenesis

TL;DR: This work has developed the first comprehensive map of endothelial cell-specific signaling events of VEGFA/VEGFR2 system pertaining to angiogenesis and believes that this map would serve as a novel platform for reference, integration, and representation and more significantly, the progressive analysis of dynamic features of V EGF signaling in endothelial cells including their cross-talks with other ligand-receptor systems involved inAngiogenesis.
Journal ArticleDOI

Potential protease inhibitors and their combinations to block SARS-CoV-2.

TL;DR: Ritonavir has the highest potency to block SARS-CoV-2 main protease and human TMPRSS2, a host cell factor that aids viral infection that helped viral fusion with the host cell membrane.
Journal ArticleDOI

Temporal VEGFA responsive genes in HUVECs: Gene signatures and potential ligands/receptors fine-tuning angiogenesis

TL;DR: An improved update-version of the previous VEGFA signaling network model in endothelial cells is presented as a platform for analysis of cross-talk with these signaling systems.
Journal ArticleDOI

Multiple Targets Directed Multiple Ligands: An In Silico and In Vitro Approach to Evaluating the Effect of Triphala on Angiogenesis

TL;DR: THL, an Indian ayurvedic herbal formulation made from the dried fruits of three medicinal plants, is used as a herbal drug for the treatment of various diseases, including cancer and the new approach developed to determine the potential efficacy of herbal formulation could be a useful strategy to assess the efficacy of different herbal formulations.
Journal ArticleDOI

Identification of Hub Genes and Key Pathways Associated with Anti-VEGF Resistant Glioblastoma Using Gene Expression Data Analysis.

TL;DR: In this paper, gene expression data of xenografts of tumors of bevacizumab-resistant glioblastoma multiforme (GBM) patients, using bioinformatics tools, were reanalyzed to understand the molecular mechanisms of this resistance.